Ontology highlight
ABSTRACT: Importance
Systemic treatments for atopic dermatitis are being evaluated primarily in placebo-controlled trials; network meta-analysis can provide relative efficacy and safety estimates for treatments that have not been compared head to head.Objective
To compare reported measures of efficacy and assessments of safety in clinical trials of systemic treatments for atopic dermatitis in a living systematic review and network meta-analysis.Data sources
The Cochrane Central Register of Controlled Trials, MEDLINE, Embase, Latin American and Caribbean Health Science Information database, Global Resource of EczemA Trials database, and trial registries were searched through June 15, 2021.Study selection
Randomized clinical trials examining 8 or more weeks of treatment
SUBMITTER: Drucker AM
PROVIDER: S-EPMC8928094 | biostudies-literature | 2022 May
REPOSITORIES: biostudies-literature